In briefing notes released ahead of a key meeting on Tuesday, scientists at the US Food and Drug Administration describe uncertainty in the risks associated wit 30 October 2023
Privately-held gene editing company Verve Therapeutics has been cleared by the US regulator to go ahead with what will be the first in-human base editing study 26 October 2023
Germany’s BioNTech has presented positive Phase I/II on its CAR-T cell therapy candidate BNT211 in advanced solid tumors at the European Society of Medical Onco 24 October 2023
Shanghai-based gene therapy company Belief BioMed (BBM) has out-licensed rights for the commercialization of its hemophilia candidate, BBM-H901, in China. 23 October 2023
Ohio, USA-based contract development and manufacturing organization (CDMO) Andelyn Biosciences has partnered with Purespring Therapeutics in the area of nephrol 20 October 2023
After scientific advisors recommended that the US regulator not approve a new amyotrophic lateral sclerosis (ALS) therapy, developer BrainStorm Cell Therapeutic 19 October 2023
Chicagoan artificial intelligence and antibody specialist SparX Biopharmaceutical is to embark on a new strategic collaboration with Arovella Therapeutics. 17 October 2023
China’s CARsgen Therapeutics has announced the publication of two cases of long-term disease-free survival in the treatment of advanced hepatocellular carcinoma 12 October 2023
At an investor day in New York, Californian biotech Ionis Pharmaceuticals outlined key clinical and commercial updates related to its progress developing RNA-ba 5 October 2023
The UK is in a strong position to become “a global leader in mRNA medicine,” according to a new report by industry cheerleader the BioIndustry Association (BIA) 4 October 2023
French contract development and manufacturing organization (CDMO) Cell-Easy, a specialist in cell therapies, has appointed Gisele Deblandre as chief scientific 28 September 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.